M&A Deal Summary

Enzymatica Acquires Zymetech ehf.

On January 28, 2016, Enzymatica acquired life science company Zymetech ehf. for 70M SEK

Acquisition Highlights
  • This is Enzymatica’s 1st transaction in the Life Science sector.
  • This is Enzymatica’s 0th largest (disclosed) transaction.
  • This is Enzymatica’s 1st transaction in Iceland.

M&A Deal Summary
Date 2016-01-28
Target Zymetech ehf.
Sector Life Science
Buyer(s) Enzymatica
Deal Type Add-on Acquisition
Deal Value 70M SEK
Advisor(s) HDR Partners (Financial)
Roschier, Attorneys (Legal)

Target

Zymetech ehf.

Reykjavik, Iceland
Zymetech ehf. is a provider of therapeutic application of marine-derived enzymes.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Enzymatica

Lund, Sweden
Category Company
Founded 2007
Sector Life Science
Employees16
Revenue 51M SEK (2023)
DESCRIPTION

Enzymatica is a life science company that develops and sells medical products against common infectious diseases. Enzymatica was founded in 2007 and is based in Lund, Sweden.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Iceland) 1 of 1
Year (2016) 1 of 1
Mergr

Product

Company

Legal